Crossmark

Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy

Crossref DOI link: https://doi.org/10.1007/s40261-018-0688-3

Published Online: 2018-09-06

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Viti, Raffaella

Marcellusi, Andrea https://orcid.org/0000-0002-3974-3798
Capone, Alessandro

Matucci, Andrea

Vultaggio, Alessandra

Pignata, Claudio

Spadaro, Giuseppe

Vacca, Angelo

Marasco, Carolina

Agostini, Carlo

Mennini, Francesco Saverio
License Information

Text and Data Mining valid from 2018-09-06
More Information

Article History

First Online: 6 September 2018

Compliance with Ethical Standards

:

: This analysis was funded by Baxalta SpA. The authors confirm that the paper is an accurate representation of the study results.

: Viti Raffaella, Marcellusi Andrea, Capone Alessandro, Matucci Andrea, Vultaggio Alessandra, Pignata Claudio, Spadaro Giuseppe, Vacca Angelo, Marasco Carolina, Agostini Carlo, and Mennini Francesco Saverio declare that there are no conflicts of interest regarding the publication of this paper.

Document is current

Any future updates will be listed below